VRCA
Verrica Pharmaceuticals Inc
NASDAQ: VRCA · HEALTHCARE · BIOTECHNOLOGY
$6.37
-3.19% today
Updated 2026-04-30
Market cap
$112.18M
P/E ratio
—
P/S ratio
3.15x
EPS (TTM)
$-1.68
Dividend yield
—
52W range
$3 – $10
Volume
0.1M
Verrica Pharmaceuticals Inc (VRCA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $544000.00 | $9.08M | $91.91M | $68.42M | $74.15M | $80.13M | $44.72M | $81.60M | $54.13M |
| Cash & equivalents | $527000.00 | $8.66M | $10.27M | $9.24M | $10.69M | $15.75M | $34.27M | $69.55M | $46.33M |
| Current assets | $544000.00 | $9.08M | $91.15M | $64.98M | $67.65M | $74.33M | $39.12M | $77.53M | $51.18M |
| Total liabilities | $3.21M | $16.12M | $2.48M | $3.41M | $41.17M | $47.52M | $4.69M | $61.83M | $63.99M |
| Current liabilities | $419000.00 | $616000.00 | $2.48M | $3.35M | $39.48M | $46.05M | $3.46M | $17.02M | $29.01M |
| Long-term debt | — | — | — | — | $35.31M | — | — | $42.87M | $30.98M |
| Shareholder equity | $-2.66M | $-7.04M | $89.43M | $65.02M | $32.99M | $32.60M | $40.03M | $19.76M | $-9.86M |
| Retained earnings | $-2.68M | $-12.44M | $-33.08M | $-61.19M | $-103.89M | $-138.97M | $-163.45M | $-230.45M | $-307.03M |
| Accounts receivable | — | — | — | — | — | $0.00 | $487000.00 | $4.42M | $77000.00 |
| Inventory | — | — | — | — | — | — | $-487000.00 | $1.02M | $2.46M |
| Goodwill | — | — | — | — | — | — | — | — | — |